Xiaoying Zhang , Qianyu Zhou , Shengjun Bu , Yuqi Yang , Lingling Wang , Chuanna Xu , Zhuo Hao , Guijuan Qu , Jiayu Wan
{"title":"A lateral flow biosensor based on duplex-specific nuclease and novel isothermal amplification for detection of influenza virus","authors":"Xiaoying Zhang , Qianyu Zhou , Shengjun Bu , Yuqi Yang , Lingling Wang , Chuanna Xu , Zhuo Hao , Guijuan Qu , Jiayu Wan","doi":"10.1016/j.enzmictec.2025.110653","DOIUrl":null,"url":null,"abstract":"<div><div>Here, we describe a lateral flow biosensor capable of detecting H1N1 virus by integrating duplex-specific nuclease (DSN) and a novel isothermal amplification, two probe isothermal amplification (TPIA). Probe A and probe B of TPIA form DNAs of varying lengths by repeated polymerization and displacement of each other. Probe A extends into single-stranded DNA (ssDNA) of varying lengths containing multiple hairpin structures. Probe B extends into double-stranded DNA hairpins of different lengths. Both the 5′ end of the single strand DNA (ssDNA) probe A and probe B were joined by a ssDNA tail via a C3 spacer. These tails were designed to be complementary to capture sequence of probe C (5 'end modifies fluorescein [FAM]) immobilized on magnetic beads. Cyclical DSN cleavage of probe C was triggered by target H1N1 RNA to release a capture sequence to capture TPIA product DNA with multiple biotins. The TPIA product/capture sequence complex of FAM can be captured by anti-FAM in the test strip test area, and the accumulation of gold nanoparticles causes a red band to appear in the test area. The limit of detection of specific RNA was as low as 829 fM with a linear range from 1 pM to 100 nM. This visual detection system is suitable for influenza A H1N1 virus point-of-care diagnosis in non-specialist personnel and low-resource settings.</div></div>","PeriodicalId":11770,"journal":{"name":"Enzyme and Microbial Technology","volume":"188 ","pages":"Article 110653"},"PeriodicalIF":3.4000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enzyme and Microbial Technology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0141022925000730","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Here, we describe a lateral flow biosensor capable of detecting H1N1 virus by integrating duplex-specific nuclease (DSN) and a novel isothermal amplification, two probe isothermal amplification (TPIA). Probe A and probe B of TPIA form DNAs of varying lengths by repeated polymerization and displacement of each other. Probe A extends into single-stranded DNA (ssDNA) of varying lengths containing multiple hairpin structures. Probe B extends into double-stranded DNA hairpins of different lengths. Both the 5′ end of the single strand DNA (ssDNA) probe A and probe B were joined by a ssDNA tail via a C3 spacer. These tails were designed to be complementary to capture sequence of probe C (5 'end modifies fluorescein [FAM]) immobilized on magnetic beads. Cyclical DSN cleavage of probe C was triggered by target H1N1 RNA to release a capture sequence to capture TPIA product DNA with multiple biotins. The TPIA product/capture sequence complex of FAM can be captured by anti-FAM in the test strip test area, and the accumulation of gold nanoparticles causes a red band to appear in the test area. The limit of detection of specific RNA was as low as 829 fM with a linear range from 1 pM to 100 nM. This visual detection system is suitable for influenza A H1N1 virus point-of-care diagnosis in non-specialist personnel and low-resource settings.
期刊介绍:
Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.
We especially encourage submissions on:
Biocatalysis and the use of Directed Evolution in Synthetic Biology and Biotechnology
Biotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and Biofuels
New Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems Biology
New Biotechnological Approaches in Genomics, Proteomics and Metabolomics
Metabolic Engineering, Biomolecular Engineering and Nanobiotechnology
Manuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.